Anziam Bio Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.80 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.15 Cr
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 572.86%
About Anziam Bio
Anziam Bio Private Limited (ABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 October 2020 (Four years and three months 12 days old ). Its registered office is in Alwar, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.80 M.
The company currently has active open charges totaling ₹5.15 Cr.
Srayance Jain, Sachin Kapoor, and Rachna Aggarwal serve as directors at the Company.
Company Details
-
Location
Alwar, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24299RJ2020PTC071704
-
Company No.
071704
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Oct 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Anziam Bio?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srayance Jain
|
Director | 21-Oct-2020 | Current |
|
Sachin Kapoor
|
Director | 21-Oct-2020 | Current |
| Rachna Aggarwal | Additional Director | 02-Sep-2024 | Current |
Financial Performance of Anziam Bio.
Anziam Bio Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anziam Bio?
In 2021, Anziam Bio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Improvate Consulting Services Private LimitedSachin Kapoor is a mutual person
Charges (Loans)
₹51.50 M
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 5.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2022 | Sidbi | ₹4.25 Cr | Open |
| 16 Sep 2022 | Sidbi | ₹9.00 M | Open |
How Many Employees Work at Anziam Bio?
Anziam Bio has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anziam Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anziam Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.